RNF2 and chronic myelogenous leukemia, BCR-ABL1 positive: We next determined the effect of these compounds on reducing the protein levels of BMI1, RING1B, EED, and H2AK119ub in K562 cells, a chronic myelogenous leukemia cell line (Figure S3, Supporting Information).